UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1951) 1951
life sciences & biomedicine (1790) 1790
humans (1600) 1600
hydroxamic acids - pharmacology (1213) 1213
animals (1189) 1189
male (784) 784
oncology (758) 758
hydroxamic acids - administration & dosage (751) 751
female (745) 745
mice (687) 687
biological and medical sciences (610) 610
histone deacetylase inhibitors - pharmacology (599) 599
medical sciences (559) 559
cell line, tumor (509) 509
hydroxamic acids - therapeutic use (493) 493
pharmacology & pharmacy (390) 390
apoptosis - drug effects (377) 377
histone deacetylase (359) 359
apoptosis (353) 353
cancer (352) 352
rats (335) 335
histone deacetylase inhibitors (333) 333
pharmacology. drug treatments (322) 322
middle aged (320) 320
tumors (307) 307
gene expression (288) 288
cell proliferation - drug effects (283) 283
aged (282) 282
antineoplastic agents - pharmacology (278) 278
histone deacetylase inhibitors - administration & dosage (270) 270
vorinostat (267) 267
adult (264) 264
cell biology (264) 264
dose-response relationship, drug (264) 264
research (264) 264
analysis (260) 260
antineoplastic agents (255) 255
drug synergism (248) 248
histone deacetylases - metabolism (239) 239
hydroxamic acids - adverse effects (235) 235
biochemistry & molecular biology (233) 233
proteins (228) 228
hematology (224) 224
histones - metabolism (223) 223
histone deacetylase inhibitors - therapeutic use (218) 218
acetylation (211) 211
antineoplastic combined chemotherapy protocols - therapeutic use (210) 210
care and treatment (210) 210
enzyme inhibitors - pharmacology (207) 207
disease models, animal (194) 194
histone deacetylase inhibitor (193) 193
chemotherapy (190) 190
treatment outcome (182) 182
hydroxamic acids - pharmacokinetics (179) 179
antineoplastic agents - therapeutic use (178) 178
hydroxamic acids - chemistry (174) 174
research article (172) 172
drug therapy (166) 166
trichostatin a (157) 157
administration, oral (156) 156
hydroxamic acid (156) 156
epigenetics (155) 155
xenograft model antitumor assays (153) 153
science & technology - other topics (152) 152
cell survival - drug effects (151) 151
health aspects (151) 151
cells, cultured (149) 149
mice, inbred c57bl (148) 148
antineoplastic agents - administration & dosage (147) 147
antineoplastic combined chemotherapy protocols - pharmacology (143) 143
chemistry (142) 142
medicine & public health (141) 141
multidisciplinary sciences (141) 141
cell cycle (140) 140
medicine (135) 135
neurosciences & neurology (135) 135
physical sciences (135) 135
gene expression regulation, neoplastic - drug effects (133) 133
cancer therapies (132) 132
mice, nude (131) 131
neurosciences (128) 128
time factors (128) 128
genetic aspects (125) 125
histones (125) 125
rats, sprague-dawley (122) 122
acetylation - drug effects (120) 120
blotting, western (120) 120
kinases (118) 118
mice, inbred balb c (118) 118
neoplasms - drug therapy (118) 118
chromatin (117) 117
clinical trials (117) 117
suberoylanilide hydroxamic acid (116) 116
matrix metalloproteinase inhibitors (112) 112
enzymes (110) 110
medicine, research & experimental (108) 108
research & experimental medicine (108) 108
panobinostat (106) 106
pharmacology/toxicology (106) 106
physiological aspects (106) 106
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2335) 2335
Japanese (28) 28
German (13) 13
French (10) 10
Russian (5) 5
Italian (4) 4
Chinese (3) 3
Dutch (3) 3
Lithuanian (1) 1
Polish (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 0028-0836, 07/2012, Volume 487, Issue 7408, pp. 482 - 485
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Gene Expression Regulation, Viral - drug effects | Humans | Hydroxamic Acids - adverse effects | Histone Deacetylase Inhibitors - administration & dosage | RNA, Viral - blood | Virus Latency - drug effects | Proviruses - drug effects | HIV-1 - growth & development | Proviruses - genetics | Hydroxamic Acids - administration & dosage | Anti-HIV Agents - therapeutic use | CD4-Positive T-Lymphocytes - virology | Hydroxamic Acids - pharmacology | Biomarkers - metabolism | HIV Infections - blood | Risk Assessment | HIV-1 - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - virology | RNA, Viral - biosynthesis | CD4-Positive T-Lymphocytes - metabolism | Viremia - drug therapy | HIV-1 - genetics | Proviruses - growth & development | Histones - drug effects | Up-Regulation - drug effects | Acetylation - drug effects | Viremia - virology | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Histones - metabolism | CD4-Positive T-Lymphocytes - drug effects | Histone Deacetylase Inhibitors - adverse effects | Physiological aspects | HIV patients | Health aspects | Vorinostat | Antiretroviral drugs | Plasma | Cell culture | Lymphocytes | Human immunodeficiency virus--HIV | Genomes | Drug therapy | Drug dosages | Index Medicus
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
Biological & pharmaceutical bulletin, ISSN 0918-6158, 2019, Volume 42, Issue 3, pp. 448 - 452
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2009, Volume 15, Issue 16, pp. 5250 - 5257
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 11, pp. 1231 - 1238
Life Sciences & Biomedicine | Oncology | Science & Technology | Kidney Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Epigenesis, Genetic | Humans | Middle Aged | Histone Deacetylase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Renal Cell - genetics | Benzofurans - administration & dosage | Male | Alanine Transaminase - blood | Benzofurans - blood | Fatigue - chemically induced | Vascular Endothelial Growth Factor A - genetics | Histone Deacetylase Inhibitors - blood | Benzofurans - pharmacokinetics | Young Adult | Histone Deacetylase Inhibitors - pharmacokinetics | Angiogenesis Inhibitors - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Hydroxamic Acids - administration & dosage | Adult | Female | Acetylation | Carcinoma, Renal Cell - drug therapy | Neutropenia - chemically induced | Drug Resistance | Histone Deacetylase 2 - genetics | Hydroxamic Acids - blood | Gene Expression | Pyrimidines - administration & dosage | Vascular Endothelial Growth Factor A - blood | Treatment Outcome | Thrombocytopenia - chemically induced | Disease Progression | Hydroxamic Acids - pharmacokinetics | Disease-Free Survival | Maximum Tolerated Dose | Aspartate Aminotransferases - blood | Aged | Histones - metabolism | Kidney Neoplasms - drug therapy | Sulfonamides - administration & dosage | Drug Resistance, Neoplasm - drug effects | Index Medicus | ORIGINAL REPORTS
Journal Article
Journal Article